Known hypersensitivity to product components (4) Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels (4) Women who are pregnant or may become pregnant (4, 8.1) Nursing mothers (4, 8.3) Co-administration with cyclosporine (4, 7.1, 12.3)
